Drugs / Shengmai San
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06214195 | Jan 2024 → Dec 2026 expected | chemotherapy-induced toxicity | Zhejiang Cancer Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Shengmai San | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06214195 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Ginseng 6g , Ophiopogon japonicus 12g ,Schisandra chinensis 5g , other secondary Chinese medicines can be added according to the doctor's judgment and the patient's...” NCT06214195 ↗ |
| Route | Oral | “decoction in water, one dose and two decoctions, taken twice a day” NCT06214195 ↗ |